Millennium Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,000
Closed -$625K 6170
2025
Q3
$625K Sell
10,000
-3,800
-28% -$207K ﹤0.01% 4939
2025
Q2
$718K Sell
13,800
-245,100
-95% -$10.9M ﹤0.01% 4653
2025
Q1
$11M Buy
258,900
+223,400
+629% +$9.64M 0.01% 2079
2024
Q4
$1.08M Sell
35,500
-139,300
-80% -$3.92M ﹤0.01% 4137
2024
Q3
$4.01M Buy
+174,800
New +$4.95M ﹤0.01% 3041
2023
Q2
Sell
-10,000
Closed -$234K 6310
2023
Q1
$234K Buy
+10,000
New +$286K ﹤0.01% 5081
2021
Q3
Sell
-7,500
Closed -$931K 6947
2021
Q2
$931K Sell
7,500
-11,100
-60% -$1.49M ﹤0.01% 4731
2021
Q1
$2.84M Buy
+18,600
New +$2.81M ﹤0.01% 3188

Other funds holding GH

Millennium Management's GH Position: Q1 2026 in Review

Millennium Management increased its Guardant Health (GH) stake by 58% in Q1 2026, buying an estimated $33.9M and bringing the position to 921,395 shares worth $85.1M. The position accounts for 0.04% of the portfolio, ranked #526.

Millennium Management first reported a position in GH in Q2 2019 and has held it in 25 quarters since. The position peaked at $142M in Q2 2025. 482 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Millennium Management held 921,395 shares of Guardant Health worth $85.1M as of Q1 2026.
  • Millennium Management bought 337,588 Guardant Health shares in Q1 2026, an estimated $33.9M.
  • Guardant Health made up 0.04% of Millennium Management's portfolio in Q1 2026, its #526 holding.
  • Millennium Management first reported a position in Guardant Health in Q2 2019 and has held it in 25 quarters since.
  • Millennium Management's Guardant Health position peaked at $142M in Q2 2025.
  • 482 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.